University spin-out Afynia secures M seed to commercialize its microRNA panel test for endometriosis | TechCrunch

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunch

Canadian biotech startup Afynia Laboratories, a spin-out from McMaster University in Ontario, has picked up $5 million in seed funding to commercialize a blood test for endometriosis — a medical condition that can afflict people with a uterus, causing problems like chronic pelvic pain and fertility issues. Endometriosis affects nearly 200 million people worldwide. Getting…

Read More
MIT spinout maps the body’s metabolites to uncover the hidden drivers of disease

MIT spinout maps the body’s metabolites to uncover the hidden drivers of disease

Biology is never simple. As researchers make strides in reading and editing genes to treat disease, for instance, a growing body of evidence suggests that the proteins and metabolites surrounding those genes can’t be ignored. The MIT spinout ReviveMed has created a platform for measuring metabolites — products of metabolism like lipids, cholesterol, sugar, and…

Read More